This week's Fierce Biotech is brought to you by Avantor.

Scaling up the harvest process while preserving what matters

Gene therapy offers incredible promise for treating inherited disorders and diseases, but the manufacturing challenges can be complex. One critical hurdle is the cell lysis process. While chemical lysis is the preferred method for scalability and consistency in viral gene therapy manufacturing, the industry-standard reagents come with significant drawbacks: But there’s good news. This whitepaper presents a novel biodegradable cell lysis solution designed to overcome these issues, offering:

• Improved efficiency of viral vector release
• Better protection for viral particles during agitation
• Reduced viscosity and foaming, simplifying handling
• Room-temperature storage and shipping for easier logistics

Learn how this innovative solution will streamline your gene therapy manufacturing process. Don’t miss out on this opportunity to optimize your gene therapy process—start reading now!